<bill session="118" type="h" number="4449" updated="2024-08-14T16:56:10Z">
  <state datetime="2023-06-30">REFERRED</state>
  <status>
    <introduced datetime="2023-06-30"/>
  </status>
  <introduced datetime="2023-06-30"/>
  <titles>
    <title type="display">Pharmaceutical Security Production Act</title>
    <title type="short" as="introduced">Pharmaceutical Security Production Act</title>
    <title type="official" as="introduced">To establish the Commission on Strengthening the Domestic Pharmaceutical Supply Chain, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="T000486"/>
  <cosponsors>
    <cosponsor bioguide_id="F000466" joined="2024-08-06"/>
    <cosponsor bioguide_id="M001221" joined="2023-12-29"/>
  </cosponsors>
  <actions>
    <action datetime="2023-06-30">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-06-30" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2023-07-07">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Unknown, Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Advisory bodies"/>
    <term name="Congressional oversight"/>
    <term name="Manufacturing"/>
    <term name="Medical research"/>
    <term name="Prescription drugs"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2024-08-14T16:55:36Z" status="Introduced in House">Pharmaceutical Security Production Act

This bill establishes the Commission on Strengthening the Domestic Pharmaceutical Supply Chain.

The commission must assess the security and vulnerabilities of the domestic pharmaceutical supply chain in the United States and recommend improvements, including by developing metrics for domestic manufacturing programs, proposing solutions to strengthen the domestic manufacturing workforce, and evaluating ways to support a financial market for domestically manufactured products.

The commission terminates four years after the bill is enacted.</summary>
</bill>
